Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017

Addiction

Volumn 112, Issue 12, 2017, Pages 2206-2216

  Klieger, Sarah B ^a   Gutman, Abraham ^a   Allen, Leslie ^b   Pacula, Rosalie Liccardo ^c   Ibrahim, Jennifer K ^a   Burris, Scott ^a  

^a TEMPLE UNIVERSITY   (United States)

^b Women Against Abuse   (United States)

^c RAND CORPORATION   (United States)

Author keywords

Drug policy; legal epidemiology; marijuana law; medical cannabis; policy surveillance; regulation

Indexed keywords

MEDICAL CANNABIS;

CANNABIS USE; COMMERCIAL PHENOMENA; DRUG CONTROL; ECONOMICS; GOVERNMENT; HUMAN; LEGISLATION AND JURISPRUDENCE; PRODUCT SAFETY; UNITED STATES;

COMMERCE; CONSUMER PRODUCT SAFETY; DRUG AND NARCOTIC CONTROL; HUMANS; MARIJUANA USE; MEDICAL MARIJUANA; STATE GOVERNMENT; UNITED STATES;

EID: 85026648610     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13910     Document Type: Article

References (46)

1. Vitiello M. Proposition 215: de facto legalization of pot and the shortcomings of direct democracy. University of Michigan Journal of Law Reform 1997–1998; 31: 707–776.
2. Pacula R. L., Smart R. Medical marijuana and marijuana legalization. Annu Rev Clin Psychol 2017; 13: 397–419.
3. Drug Enforcement Administration. Drug Scheduling. United States drug enforcement administration; 2016. Available at: http://www.dea.gov/druginfo/ds.shtml; http://www.webcitation.org/6qv4MVD5s (accessed 1 June 2016) (Archived at http://www.webcitation.org/6qv4MVD5s on 2 June 2017).
4. Rosenbaum S. Gonzales V. Raich: implications for public health policy. Law Public Health 2005; 120: 680–682.
5. Cole J. M. Guidance Regarding Marijuana Enforcement. Memorandum. Washington, DC: United States Department of Justice 29 August 2013. Report no.
6. Consolidated and further continuing Appropriations Act of 2015. S 538 113th Cong. 2015.
7. Commerce, Justice, Science, and related agencies Appropriations Act of 2016. 2016;S. 542, 114th Cong.
8. Caulkins J. P., Kilmer B., Kleiman M. Marijuana Legalization: What Everyone Needs to Know, 2nd edn. ed. xvi edn. Oxford: Oxford University Press; 2012, p. 284.
9. Annas G. Medical marijuana, physicians, and state law. N Engl J Med 2014; 371: 983–985.
10. Adler J. N., Colbert J. A. Clinical decisions. Medicinal use of marijuana—polling results. N Engl J Med 2013; 368: e30.
11. Lynch M. E., Ware M. A. Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J Neuroimmune Pharmacol 2015; 10: 293–301.
12. National Academy of Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: National Academies Press; 2017.
13. Whiting P. F., Wolff R. F., Deshpande S., Di Nisio M., Duffy S., Hernandez A. V. et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456–2473.
14. Koppel B. S., Brust J. C., Fife T., Bronstein J., Youssof S., Gronseth G. et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development Subcommittee of the American Academy of Neurology. Neurology 2014; 82: 1556–1563.
15. Health Insurance Portability and Accountability Act of 1996 (‘HIPAA’), pub. L. no. pub. L. 104–191(August 21, 1996, 1996).
16. Rendall R. Medical marijuana and the ADA—removing barriers to employment for disabled individuals. Health Matrix 2012; 22: 315–343.
17. Williams A. R., Olfson M., Kim J. H., Martins S. S., Kleber H. D. Older, less regulated medical marijuana programs have much greater enrollment rates than newer ‘medicalized’ programs. Health Aff 2016; 35: 480–488.
18. Ferraiolo K. State policy innovation and the Federalism implications of direct democracy. Publius 2007; 38: 488–514.
19. Wen H., Hockenberry J. M., Cummings J. R. The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ 2015; 42: 64–80.
20. Mark Anderson D., Hansen B., Rees D. I. Medical marijuana laws and teen marijuana use. Am Law Econ Rev 2015; 17: 495–528.
21. Hasin D. S., Wall M., Keyes K. M., Cerdá M., Schulenberg J., O'Malley P. M. et al. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2015; 2: 601–608.
22. Sevigny E. L., Pacula R. L., Heaton P. The effects of medical marijuana laws on potency. Int J Drug Policy 2014; 25: 308–319.
23. Morris R. G., TenEyck M., Barnes J. C., Kovandzic T. V. The effect of medical marijuana laws on crime: evidence from state panel data, 1990–2006. PLOS ONE 2014; 9: e92816.
24. Masten S. V., Guenzburger G. V. Changes in driver cannabinoid prevalence in 12 U.S. states after implementing medical marijuana laws. J Safety Res 2014; 50: 35–52.
25. Chu Y. W. The effects of medical marijuana laws on illegal marijuana use. J Health Econ 2014; 38: 43–61.
26. Choo E. K., Benz M., Zaller N., Warren O., Rising K. L., McConnell K. J. The impact of state medical marijuana legislation on adolescent marijuana use. J Adolesc Health 2014; 55: 160–166.
27. Lynne-Landsman S. D., Livingston M. D., Wagenaar A. C. Effects of state medical marijuana laws on adolescent marijuana use. Am J Public Health 2013; 103: 1500–1506.
28. Anderson D. M., Hansen B., Rees D. I. Medical marijuana laws, traffic fatalities, and alcohol consumption. J Law Econ 2013; 56: 333–369.
29. Cerda M., Wall M., Keyes K. M., Galea S., Hasin D. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend 2012; 120: 22–27.
30. Bachhuber M. A., Saloner B., Cunningham C. O., Barry C. L. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern Med 2014; 174: 1668–1673.
31. Pacula R. L., Hunt P., Boustead A. Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States. J Drug Policy Anal 2014; 7: 1–19.
32. Pacula R. L., Powell D., Heaton P., Sevigny E. L. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J Policy Anal Manage 2015; 34: 7–31.
33. Ritter A., Livingston M., Chalmers J., Berends L., Reuter P. Comparative policy analysis for alcohol and drugs: current state of the field. Int J Drug Policy 2016; 31: 39–50.
34. Krippendorff K. Validity in content analysis. In: Mochmann E., editor. Computerstrategien fuer die kommunikationsanalyse [Computer Strategies for Communication Analysis]. Frankfurt: Campus-Verlag; 1980, pp. 69–112.
35. Anderson E., Tremper C., Thomas S., Wagenaar A. C. Measuring statutory law and regulations for empirical research. In: Wagenaar A., Burris S., editors. Public Health Law Research: Theory and Methods. San Francisco: John Wiley & Sons; 2013, pp. 237–260.
36. Ogden D. W. Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana. Washington, DC: United States Department of Justice; 2009.
37. Monte A. A., Zane R. D., Heard K. J. The implications of marijuana legalization in Colorado. JAMA 2015; 313: 241–242.
38. Larkin P. J. Jr. Medical or recreational marijuana and drugged driving. Am Crim L Rev 2015; 52: 453–1659.
39. Salomonsen-Sautel S., Min S.-J., Sakai J. T., Thurstone C., Hopfer C. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend 2014; 140: 137–144.
40. Caplan G. Medical marijuana: a study of unintended consequences. McGeorge Law Review 2012; 43: 127.
41. Wang G., Roosevelt G., Heard K. Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr 2013; 167: 630–633.
42. Pacula R. L., Kilmer B., Wagenaar A. C., Chaloupka F. J., Caulkins J. P. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health 2014; 104: 1021–1028.
43. Kilmer B., Pacula R. L. Understanding and learning from the diversification of cannabis supply laws. Addiction. 2017; 112: 1128–1135.
44. Pacula R., MacCoun R., Reuter P., Chriqui J. F., Kilmer B., Harris K. et al. What does it mean to decriminalize cannabis? A cross-national empirical examination. In: Lindgren B., Grossman M., editors. Substance Use: Individual Behavior, Social Interactions, Markets and Politics. Amsterdam: Elsevier; 2005, pp. 347–370.
45. Naimi T. S., Blanchette J., Nelson T. F., Nguyen T., Oussayef N., Heeren T. C. et al. A new scale of the U.S. alcohol policy environment and its relationship to binge drinking. Am J Prev Med 2014; 46: 10–16.
46. National Conference of State Legislatures. State Medical Marijuana Laws. National Conference of State Legislatures; 2017. Available at: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (accessed 14 March 2017) (Archived at http://www.webcitation.org/6qv4nUpXN on 2 June 2017).